
30+ pharma firms accelerate clinical trials for new cutaneous T-cell lymphoma drugs
Over 30 pharmaceutical companies are actively developing more than 30 drugs for cutaneous T-cell lymphoma (CTCL), a rare skin-related non-Hodgkin lymphoma. Key players like Prescient Therapeutics and Innate Pharma are advancing promising therapies th...


